Found: 2
Select item for more details and to access through your institution.
Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 153, doi. 10.1038/s41416-023-02272-4
- By:
- Publication type:
- Article
Effectiveness of [<sup>67</sup>Cu]Cu-trastuzumab as a theranostic against HER2-positive breast cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 7, p. 2070, doi. 10.1007/s00259-024-06648-3
- By:
- Publication type:
- Article